GlassScriptPhysician profile
Jarrett T Mcgehee
NPI 1396774063
$9,088.64
in general payments reported to CMS, 2019-2025
34 companies · $1,008 in 2025
The $1,008 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $888 · 2020: $1,181 · 2021: $1,932 · 2022: $1,436 · 2023: $1,455 · 2024: $1,188 · 2025: $1,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,651.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,142.85 | 2020-2025 | |
| Abiomed | $940.66 | 2019-2025 | Impella |
| Janssen Pharmaceuticals, INC | $783.75 | 2019-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $725.16 | 2019-2025 | Onpattro, Amvuttra |
| Pfizer INC. | $621.95 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $517.81 | 2021-2025 | Verquvo |
| Amgen INC. | $464.98 | 2019-2025 | Repatha, Repatha |
| Esperion Therapeutics, INC. | $440.27 | 2020-2023 | Nexletol |
| Amarin Pharma, INC. | $428.07 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $390.69 | 2020-2025 | Jardiance |
| Celonova Biosciences, INC. | $386.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $297.95 | 2019-2025 | Farxiga, Brilinta |
| Boston Scientific Corporation | $279.35 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $257.93 | 2019-2024 | Lifevest |
| Sanofi-Aventis U.S. LLC | $216.48 | 2019-2024 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $167.51 | 2019-2021 | |
| Shockwave Medical, INC | $148.56 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.54 | 2024-2025 | |
| Scpharmaceuticals INC. | $113.08 | 2024-2025 | |
| Irhythm Technologies, INC. | $107.10 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $75.40 | 2020-2025 | Camzyos, Eliquis |
| Glaxosmithkline, LLC. | $59.96 | 2025 | Shingrix, Arexvy |
| Azurity Pharmaceuticals, INC. | $58.32 | 2023-2024 | Edarbi, Edarbi |
| Lundbeck LLC | $55.27 | 2020-2021 | |
| Impulse Dynamics (USA) INC. | $54.05 | 2023 | Optimizer |
| Lexicon Pharmaceuticals, INC. | $46.86 | 2023-2024 | Inpefa |
| Kiniksa Pharmaceuticals, LTD. | $31.09 | 2023 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $28.99 | 2019 | |
| Allergan, INC. | $24.53 | 2019 | |
| Medicomp INC | $21.05 | 2025 | Telepatch Cardiac Monitor |
| Althera Pharmaceuticals LLC | $18.17 | 2021 | |
| Agepha Pharma Fz LLC | $16.24 | 2024 | Lodoco |
| Avinger INC. | $13.71 | 2021 | |
| Preventice Services, LLC | $12.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jarrett Mcgehee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.